CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570) Eye Health (703)
BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. Worldwide, the...Show all
Company (Alive / Active)
Phone: 617-252-4343
55 Cambridge Parkway
Suite 301
Cambridge, 02142
Massachusetts, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Bikam Pharmaceuticals | $11M | Nov 23, 2007 |
| Memory Pharmaceuticals | $191.2M | Nov 26, 2008 |
| Innoviva | $257.7M | Oct 5, 2004 |
| See all 45 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Opsin-binding ligands, compositions and methods of use | Nov 29, 2012 | Aug 07, 2018 | Patent |
| Opsin-binding ligands, compositions and methods of use | Apr 21, 2016 | Sep 12, 2017 | Patent |
| Opsin-binding ligands, compositions and methods of use | Jun 16, 2010 | Feb 07, 2017 | Patent |
| Opsin-binding ligands, compositions and methods of use | Oct 19, 2012 | Nov 22, 2016 | Patent |
| Opsin-binding ligands, compositions and methods of use | Aug 13, 2015 | Oct 04, 2016 | Patent |
